Screening for Hematology Branch Protocols

Part of paid clinical trials in Bethesda, Maryland.

Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Study ID
NCT00001620
Status
Enrolling By Invitation

Conditions

  • Donors
  • Healthy Volunteer
  • Hematologic Disease and Disorders

Eligibility Criteria

Sex
ALL
Age
2 Years - 100 Years
Healthy Volunteers
Accepted

Study Details

This study allows the evaluation of subjects in order to determine their ability to safely participate in other active research studies. After subjects complete the screening process, they will be offered the opportunity to participate in an active research study, or if no appropriate studies are available information and recommendations will be provided for other treatment options....

Key Dates

Start date
Dec 31, 1996
Status verified
May 2026

Study Design

Enrollment
10,000 participants (estimated)

Arms

  • Arm: Subjects undergoing screening
    Adults and children being screened for an active NHLBI protocol

Primary Outcome Measure

Primary endpoint is the results of clinical, imaging and laboratory assessments. [ Time Frame: ongoing ]

Locations (1)

FacilityCityStateZIPSite coordinators
National Institutes of Health Clinical CenterBethesdaMaryland20892-

Find similar trials in Bethesda, MD

By research site
National Institutes of Health Clinical Center· Bethesda, MD

Related Studies